These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 79764)

  • 41. [Experimental vaccinal prophylaxis of Pseudomonas aeruginosa burn sepsis].
    Bandman OA; Stanislavskiĭ ES; Kholodkova EV; Ivanova TV; Salov VF
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):59-62. PubMed ID: 2510430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemilogy of Pseudomonas in a burn intensive care unit.
    MacMillar BG; Edmonds P; Hummel RP; Maley MP
    J Trauma; 1973 Jul; 13(7):627-38. PubMed ID: 4197546
    [No Abstract]   [Full Text] [Related]  

  • 43. Measurement of endotoxins with the limulus test in burned patients.
    Jones RJ; Roe EA
    J Hyg (Lond); 1979 Aug; 83(1):151-6. PubMed ID: 110875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic utilization of an antipseudomonas aeruginosa vaccine in a severe burn unit.
    Wassermann D; Schlotterer M; Paul P; Rieu M
    Scand J Plast Reconstr Surg; 1979; 13(1):81-4. PubMed ID: 451484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
    Sachs A
    Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
    [No Abstract]   [Full Text] [Related]  

  • 47. Spread of Pseudomonas aeruginosa in a burns unit.
    Liljedahl SO; Malmborg AS; Nyström B; Sjöberg L
    J Med Microbiol; 1972 Nov; 5(4):473-81. PubMed ID: 4630338
    [No Abstract]   [Full Text] [Related]  

  • 48. The intestinal tract as a portal of entry of Pseudomonas in burned rats.
    Howerton EE; Kolmen SN
    J Trauma; 1972 Apr; 12(4):335-40. PubMed ID: 4111798
    [No Abstract]   [Full Text] [Related]  

  • 49. Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations.
    Krokhina MA; Grishina IA; Panova YuM ; Terekhova RP; Severtsova MK; Yedvabnaya LS; Vaide M; Varro R; Rusanov VM; Kolker II
    Vaccine; 1985 Sep; 3(3):316-24. PubMed ID: 3933202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 51. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early protection by vaccines in burns.
    Jones RJ
    Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model.
    Laghaei P; Hashemi FB; Irajian G; Korpi F; Amirmozafari N; Behrouz B
    Mol Immunol; 2016 Jun; 74():71-81. PubMed ID: 27152476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
    Holder IA; Naglich JG
    J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
    Meitert E; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
    [No Abstract]   [Full Text] [Related]  

  • 56. Alternative forms of local treatment for burns.
    Lowbury EJ; Lilly HA; Cason JS; Jackson DM; Bull JP; Davies JW; Ford PM
    Lancet; 1971 Nov; 2(7734):1105-11. PubMed ID: 4107394
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subeschar treatment of burn-wound infection.
    McManus WF; Goodwin CW; Pruitt BA
    Arch Surg; 1983 Mar; 118(3):291-4. PubMed ID: 6824429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serological failure of Pseudomonas vaccination in patients receiving multiple chemotherapy.
    Bannister P; Mellor J
    J Biol Stand; 1985 Oct; 13(4):321-6. PubMed ID: 3932361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Naqvi SH; Naqvi SH
    S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.